Name | 3-[2-(4-methylsulfonylphenyl)ethenyl]-1,2,4-oxadiazole |
---|---|
Synonyms |
3-(4-Methylsulfonylstyryl)-1,2,4-oxadiazole
1,2,4-Oxadiazole,3-[p-(methylsulfonyl)styryl]-,(E)-(8CI) 1,2,4-Oxadiazole,3-[(1E)-2-[4-(methylsulfonyl)phenyl]ethenyl] 3-trans-p-methylsulphonylstyryl-1,2,4-oxadiazole 1,2,4-Oxadiazole,3-[2-[4-(methylsulfonyl)phenyl]ethenyl]-,(E) 3-(trans-4-methanesulfonyl-styryl)-[1,2,4]oxadiazole 3-[(E)-2-(4-methylsulfonylphenyl)ethenyl]-1,2,4-oxadiazole BTI 2571E |
Density | 1.362g/cm3 |
---|---|
Boiling Point | 479ºC at 760mmHg |
Molecular Formula | C11H10N2O3S |
Molecular Weight | 250.27400 |
Flash Point | 243.5ºC |
Exact Mass | 250.04100 |
PSA | 81.44000 |
LogP | 2.72430 |
Vapour Pressure | 0mmHg at 25°C |
Index of Refraction | 1.592 |
HS Code | 2934999090 |
---|
~98% 24664-14-0 |
Literature: Glaxo Laboratories Limited Patent: US4012377 A1, 1977 ; |
Precursor 1 | |
---|---|
DownStream 0 |
HS Code | 2934999090 |
---|---|
Summary | 2934999090. other heterocyclic compounds. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |